Insulin-like Growth Factor 1 Ameliorates Intestinal Barrier Dysfunction in MASLD via IGF-1R/PI3K/AKT Signaling
Nutrients · 22.05.2026 · 18 (11) · 1667
DOI: 10.3390/nu18111667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 22.05.2026. Verfasst von Wenshuo Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Liaoning Provincial Key Laboratory of Zoonosis, College of Animal Science & Veterinary Medicine, Shenyang Agricultural University, Shenyang 110866, C…. Hauptthemen laut MEDLINE: Intestinal Barrier Function, Intestinal Mucosa, Non-alcoholic Fatty Liver Disease, Signal Transduction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Liaoning Modern Agricultural Industry Technology System Construction Project of Broiler Industry.
Abstract (Originalsprache)
Background
Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a globally prevalent hepatic disorder, characterized by hepatic lipid accumulation and extrahepatic complications, notably intestinal barrier injury, which further exacerbates MASLD progression. The “gut–liver axis” has been identified as a critical contributor to MASLD development, with insulin-like growth factor 1 (IGF-1) serving as a pivotal coupling factor of this axis. However, the specific role and molecular mechanism by which IGF-1 modulates intestinal barrier function in the context of MASLD remains unclear.
Methods
This study analyzed the correlations between the GH/IGF-1 axis and intestinal barrier function in MASLD rats, and explored the effects of IGF-1 intervention both in vivo and in vitro.
Results
Our results showed that MASLD rats exhibited intestinal barrier impairment, characterized by elevated serum Diamine oxidase (DAO) and D-Lactate (D-LAC) levels, villus damage, and downregulation of tight junction proteins and Mucin (MUC2). These changes were accompanied by suppression of the GH/IGF-1 axis. Correlation analysis uncovered a negative association between IGF-1 levels and markers of barrier dysfunction. IGF-1 intervention effectively repaired the intestinal barrier structure of MASLD rats and significantly upregulated the expressions of IGF-1R, PI3K, and AKT. In vitro, IGF-1 treatment improved transepithelial electrical resistance (TEER), enhanced barrier-related gene expression, promoted cell proliferation, and inhibited apoptosis.
Conclusions
These findings suggested that GH/IGF-1 axis suppression, intestinal barrier dysfunction, and IGF-1R/PI3K/AKT signaling were interconnected within the gut–liver axis in MASLD. IGF-1 may contribute to barrier regulation through associated signaling changes, highlighting the GH/IGF-1 axis as a potential complementary target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liaoning Provincial Key Laboratory of Zoonosis, College of Animal Science & Veterinary Medicine, Shenyang Agricultural University, Shenyang 110866, China.
ORCID-Profile: Jiancheng Yang
Förderung
- National Natural Science Foundation of China
- Liaoning Modern Agricultural Industry Technology System Construction Project of Broiler Industry
Zitieren
APA
Zhao, W., San, J., Jiang, F., Zhu, Y., Wu, G., Yang, J., & Li, W. (2026). Insulin-like Growth Factor 1 Ameliorates Intestinal Barrier Dysfunction in MASLD via IGF-1R/PI3K/AKT Signaling. Nutrients, 18(11), 1667. https://doi.org/10.3390/nu18111667
Vancouver
Zhao W, San J, Jiang F, Zhu Y, Wu G, Yang J, et al. Insulin-like Growth Factor 1 Ameliorates Intestinal Barrier Dysfunction in MASLD via IGF-1R/PI3K/AKT Signaling. Nutrients. 2026;18(11):1667. doi:10.3390/nu18111667
BibTeX
@article{Zhao2026,
author = {Zhao, Wenshuo and San, Jishuang and Jiang, Fan and Zhu, Yue and Wu, Gaofeng and Yang, Jiancheng and Li, Weiwei},
title = {Insulin-like Growth Factor 1 Ameliorates Intestinal Barrier Dysfunction in MASLD via IGF-1R/PI3K/AKT Signaling},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {11},
pages = {1667},
doi = {10.3390/nu18111667}
}
EUVIMED